Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Natural killer cells for cancer immunotherapy: a new CAR is catching up

1 Jan 2019

Abstract excerpt

Immunotherapy has revolutionised cancer treatment. Since the approval of ipilimumab (an anti-cytotoxic T lymphocyte antigen [CTLA]-4 monoclonal antibody) in 2011 for the treatment of patients with malignant melanoma, immune checkpoint inhibitors such as anti-PD-1, anti-PD-L1, and anti-CTLA-4 have demonstrated their power in the clinic to treat previously untreatable terminal tumours. These success stories finally...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Immune Cell Function and Interaction
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30685121
DOI: 10.1016/j.ebiom.2019.01.018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Natural killer cells for cancer immunotherapy: a new CAR is catching upPMID 30685121Read ↗

Advantages and clinical applications of natural killer cells in cancer immunotherapy.Semantic proximity Read ↗

Chimeric antigen receptor-natural killer cell therapy: a new force in intrinsic immunotherapy for cancer treatmentSemantic proximity Read ↗

Cytotoxic CD8+ T cells in cancer and cancer immunotherapySemantic proximity Read ↗

Killer instincts: natural killer cells as multifactorial cancer immunotherapySemantic proximity Read ↗

The Role of Natural Killer T Cells in Cancer—A Phenotypical and Functional ApproachSemantic proximity Read ↗

A structural, genetic and clinical comparison of CAR-T cells and CAR-NK cells: companions or competitors?Semantic proximity Read ↗

The labyrinthine ways of cancer immunotherapy--T cell, tumor cell encounter: "how do I lose thee? Let me count the ways".Semantic proximity Read ↗

NKT cells - New players in CAR cell immunotherapy?Semantic proximity Read ↗

Five decades of natural killer cell discoverySemantic proximity Read ↗

Cancer T-cell therapy: building the foundation for a cureSemantic proximity Read ↗

New horizons in cancer immunotherapy: The evolving role of R848 and R837 (Review)Semantic proximity Read ↗

Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.